TY - JOUR
T1 - Retinoblastoma protein-interacting zinc finger 1, a tumor suppressor, augments lipopolysaccharide-induced proinflammatory cytokine production via enhancing nuclear factor-κB activation
AU - Noman, Abu Shadat Mohammod
AU - Koide, Naoki
AU - Iftakhar-E-Khuda, Imtiaz
AU - Dagvadorj, Jargalsaikhan
AU - Tumurkhuu, Gantsetseg
AU - Naiki, Yoshikazu
AU - Komatsu, Takayuki
AU - Yoshida, Tomoaki
AU - Yokochi, Takashi
N1 - Funding Information:
This work was supported by in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan. We are grateful to Kazuko Takahashi and Akiko Morikawa for the technical assistance.
PY - 2010
Y1 - 2010
N2 - The involvement of retinoblastoma protein-interacting zinc finger 1 (RIZ1), a tumor suppressor, in lipopolysaccharide (LPS)-induced inflammatory responses was investigated by using RAW 264.7 macrophage-like cells. LPS significantly augmented the expression of RIZ1 and the augmentation was mediated by the activation of nuclear factor (NF)-κB and Akt. The silencing of RIZ1 with the siRNA led to the inactivation of NF-κB in response to LPS. Moreover, the RIZ1 silencing caused the down-regulation of p53 activation and a p53 pharmacological inhibitor attenuated the RIZ1 expression. LPS-induced tumor necrosis factor-α and interleukin-6 production was prevented by RIZ1 siRNA or a p53 pharmacological inhibitor. Therefore, RIZ1 was suggested to augment LPS-induced NF-κB activation in collaboration with p53 and enhance the production of proinflammatory cytokines in response to LPS.
AB - The involvement of retinoblastoma protein-interacting zinc finger 1 (RIZ1), a tumor suppressor, in lipopolysaccharide (LPS)-induced inflammatory responses was investigated by using RAW 264.7 macrophage-like cells. LPS significantly augmented the expression of RIZ1 and the augmentation was mediated by the activation of nuclear factor (NF)-κB and Akt. The silencing of RIZ1 with the siRNA led to the inactivation of NF-κB in response to LPS. Moreover, the RIZ1 silencing caused the down-regulation of p53 activation and a p53 pharmacological inhibitor attenuated the RIZ1 expression. LPS-induced tumor necrosis factor-α and interleukin-6 production was prevented by RIZ1 siRNA or a p53 pharmacological inhibitor. Therefore, RIZ1 was suggested to augment LPS-induced NF-κB activation in collaboration with p53 and enhance the production of proinflammatory cytokines in response to LPS.
UR - http://www.scopus.com/inward/record.url?scp=77955096671&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955096671&partnerID=8YFLogxK
U2 - 10.1016/j.cellimm.2010.05.007
DO - 10.1016/j.cellimm.2010.05.007
M3 - Article
C2 - 20557878
AN - SCOPUS:77955096671
SN - 0008-8749
VL - 264
SP - 114
EP - 118
JO - Cellular Immunology
JF - Cellular Immunology
IS - 2
ER -